ERNA short interest
Ernexa Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 19,725 |
|---|---|
| Change vs prior report | 5,364 (+37.4%) |
| Change over six months | -87.7% |
| Days to cover | 1.00 (sector: 3.78) |
| Average daily volume | 23,717 |
| Rank in Healthcare | not ranked (OTC, fund or thinly traded) |
ERNA short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 19,725 | +37.4% | 1.00 | 23,717 |
| 2026-09-15 | 14,361 | -27.5% | 1.00 | 69,218 |
| 2026-08-31 | 19,798 | -19.7% | 1.00 | 36,104 |
| 2026-08-14 | 24,656 | +68.8% | 1.00 | 47,948 |
| 2026-07-31 | 14,605 | -0.9% | 1.00 | 111,110 |
| 2026-07-15 | 14,740 | -49.8% | 1.00 | 2,478,882 |
| 2026-06-30 | 29,381 | -27.6% | 1.00 | 69,259 |
| 2026-06-15 | 40,604 | -9.4% | 1.00 | 45,433 |
| 2026-05-29 | 44,811 | -72.4% | 1.00 | 99,259 |
| 2026-05-15 | 162,618 | +21.7% | 1.00 | 8,817,187 |
| 2026-04-30 | 133,586 | -33.6% | 1.00 | 499,796 |
| 2026-04-15 | 201,143 | +25.4% | 1.00 | 866,843 |
| 2026-03-31 | 160,378 | +74.1% | 1.00 | 1,095,252 |
| 2026-03-13 | 92,109 | -62.7% | 1.00 | 1,633,921 |
| 2026-02-27 | 247,054 | +136.9% | 1.00 | 4,663,750 |
| 2026-02-13 | 104,299 | -22.4% | 1.00 | 2,250,315 |
| 2026-01-30 | 134,358 | -3.0% | 1.00 | 311,205 |
| 2026-01-15 | 138,506 | +30.7% | 1.00 | 317,861 |
| 2025-12-31 | 105,975 | -10.6% | 2.60 | 40,725 |
| 2025-12-15 | 118,475 | -7.4% | 2.10 | 56,543 |
| 2025-11-28 | 127,901 | -22.0% | 3.82 | 33,501 |
| 2025-11-14 | 164,070 | -77.0% | 1.04 | 157,201 |
| 2025-10-31 | 713,392 | +1701.5% | 1.00 | 18,145,885 |
| 2025-10-15 | 39,599 | -28.6% | 1.00 | 75,654 |
| 2025-09-30 | 55,470 | +47.9% | 1.00 | 229,439 |
import finzdata as yf
yf.Ticker("ERNA").short_interest # every report since 2017
yf.Client().short_interest(["ERNA"], start="2018-01-01")Healthcare short interest · ERNA price history · Who owns ERNA · All short interest